Skip to content

Released Nov 2, 2022, after the close

10-Q filed Nov 3, 2022, 34 days after period end · 0001653477-22-000042

Q3 2022 · 10-Q
Revenue$482.00M+27.9% vs Q3 2021+14.8% vs Q2 2022
Net Income$75.40MN/M vs Q3 2021+26.1% vs Q2 2022
EPS Diluted$1.98N/M vs Q3 2021+28.6% vs Q2 2022
Gross Profit$176,300,000+24.3%
Operating Income$138,200,000+15.6%
Operating Cash Flowderived$100,100,000±0.0%
Free Cash Flowderived$64,000,000−14.2%
Margins · derived
Gross margin36.6%−1.1 pt vs Q3 2021
Operating margin28.7%−3.0 pt vs Q3 2021
Net margin15.6%+16.8 pt vs Q3 2021

What the release said

The release

Same quarter

MetricQ3 2022Q3 2021Q3 2020Q3 2019
Revenue$482.00M$376.80M$331.70M$359.90M
Net Income$75.40M-$4.20M$69.90M$59.90M
EPS Diluted$1.98-$0.11$1.69$1.41

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR